Related Experiment Videos
The IL-2/IL-2 receptor system: a target for rational immune intervention
1National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Immunology Today
|June 1, 1993
Summary
Interleukin 2 (IL-2) and its receptor are key to T-cell activation. Targeting the IL-2 receptor offers new strategies for preventing transplant rejection and treating autoimmune diseases and cancers.
Area of Science:
- Immunology
- Molecular Biology
- Clinical Medicine
Background:
- Interleukin 2 (IL-2) and its receptor (IL-2R) are crucial for T-cell activation.
- Dysregulation of the IL-2/IL-2R system is implicated in various diseases.
- Understanding this system allows for targeted immune interventions.
Purpose of the Study:
- To review the clinical applications of IL-2 and related therapies.
- To explore novel therapeutic strategies targeting the IL-2 receptor.
- To discuss the potential of IL-2R-directed therapy in managing immune-related disorders.
Main Methods:
- Review of existing literature on IL-2 and IL-2R.
- Discussion of clinical trials and therapeutic outcomes.
- Analysis of the mechanisms underlying IL-2R-targeted interventions.
Main Results:
- IL-2 plays a pivotal role in T-cell activation and immune responses.
- Inhibitors of IL-2 synthesis and action have therapeutic potential.
- Anti-IL-2 receptor therapy shows promise in specific clinical contexts.
Conclusions:
- Targeting the IL-2 receptor provides a novel approach for immune intervention.
- Therapies directed against the IL-2 receptor can prevent allograft rejection.
- These therapies are also beneficial for treating graft-versus-host disease, autoimmune disorders, and certain cancers.